RecruitingNCT00830557

Collecting Medical Information and Tissue Samples From Patients With Pancreatic Cancer or Other Pancreatic Disorders

Biospecimen Resource for Pancreas Disease, a Data & Tissue Bank (Also Known as a Bio-repository, Bio-bank, Data & Tissue Database, Data & Tissue Registry, Etc.) to Help Advance Research in Pancreas Disease

Sponsor

Mayo Clinic

Enrollment

20,000 participants

Start Date

Oct 1, 2000

Study Type

OBSERVATIONAL

Conditions

Pancreatic Cancer Pancreatic Adenocarcinoma Pancreatic Neuroendocrine Carcinoma Chronic Pancreatitis Hereditary Pancreatitis Acute Pancreatitis Pancreatic Disease Islet Cell Tumor

Summary

RATIONALE: Gathering medical information and collecting and storing samples of blood and tissue to test in the laboratory may help doctors develop better ways to screen people at risk for pancreatic cancer or other pancreatic disorders in the future. PURPOSE: This clinical trial is collecting medical information and tissue samples from patients with pancreatic cancer or other pancreatic disorders.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is collecting medical information and tissue samples from people with pancreatic diseases — including cancer, cysts, and pancreatitis — to support research into early detection and treatment of pancreatic conditions. **You may be eligible if...** - You have a known or suspected pancreatic disease (pancreatic cancer, islet cell cancer, pancreatic cysts, or pancreatitis) - You are a family member of a deceased participant who did not complete the study before passing away **You may NOT be eligible if...** - You are under 18 years old - You are unable to provide informed consent - You are a prison inmate Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.